Los Angeles, CA, United States of America

Dong Sung An

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dong Sung An

Introduction

Dong Sung An is a prominent inventor based in Los Angeles, California, known for his significant contributions to the field of genetic engineering and molecular biology. With a remarkable portfolio of nine patents, his work has advanced the understanding and application of small RNA technologies in medical treatments, especially in the context of genetic modifications and antiviral therapies.

Latest Patents

Among Dong Sung An's latest patents are pioneering technologies that utilize short hairpin RNA (shRNA734) to enhance the selection and elimination of genetically modified cells. This innovative shRNA734 targets human Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) and improves gene-modified stem cell engraftment through a unique conditioning and in vivo selection strategy. The methodologies enabled by his patent have vital applications, including knocking down HPRT in cells, conferring resistance to guanine analog antimetabolites, creating selectable genetically modified cells, and selecting or removing specific cells within a population. Moreover, his method for expressing small antiviral RNA molecules aims to reduce cytotoxicity in cells while effectively contributing to the treatment of subjects infected with HIV.

Career Highlights

Dong Sung An has collaborated with distinguished research institutions, notably the California Institute of Technology (Caltech) and the University of California. These affiliations have allowed him to bridge academic research with practical applications, propelling innovations in genetic engineering forward. His research efforts have positioned him as an influential figure in biotechnology, particularly in developing therapies aimed at infectious diseases and genetic disorders.

Collaborations

Throughout his career, Dong has partnered with renowned scientists such as David Baltimore and Xiao-Feng Qin. These collaborations have fostered a dynamic exchange of ideas and expertise, further amplifying the impact of his research in the scientific community. Together, they have explored novel approaches to gene editing and its therapeutic implications.

Conclusion

Dong Sung An’s inventive spirit and commitment to advancing genetic engineering underscore his importance in today’s scientific landscape. His nine patents reflect innovative strides in utilizing RNA technologies for improving human health, illustrating the intersection of ingenuity and practical application in biotechnology. His ongoing collaborations and research endeavors promise to continue shaping the future of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…